PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
09-Jun-2021 Orion’s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy Orion Corporation
09-Jun-2021 Global Antiseptics and Disinfectants Market Report Up to 2031: Visiongain Research,Inc. Visiongain
09-Jun-2021 Medidata Launches myMedidata Registries to Transform Awareness, Access, and Retention of Patients in Clinical Trials Medidata
09-Jun-2021 iTeos Therapeutics kündigt neue Daten seiner Phase-I/IIa-Studie bei der ASCO-Tagung 2021 an, die auf eine Anti-Tumor-Wirkung seines Adenosin-A2A-Rezeptorantagonisten Inupadenant hinweisen iTeos Therapeutics
09-Jun-2021 Lab Automation Market to Reach USD 5.5 billion by 2025 - Rising Market for Genomics Is Driving The Growth Of Market MarketsandMarkets Research Private Ltd.
09-Jun-2021 Enteral Feeding Devices Market to Reach USD 4.4 billion by 2025 – Growing Demand of Feeding Tubes is Key Growth Factor MarketsandMarkets Research Private Ltd.
09-Jun-2021 Mass Spectrometry Market to Reach USD 5.6 billion by 2025 - Growing Use in Metabolomics R&D In The Pharmaceutical Industry MarketsandMarkets Research Private Ltd.
09-Jun-2021 Medical Aesthetics Market to Reach USD 15.9 billion by 2025 - Increasing Focus on Facial Aesthetics to Aid Market Growth MarketsandMarkets Research Private Ltd.
08-Jun-2021 Covance will soon be Labcorp Drug Development Covance
08-Jun-2021 OXURION Completes Patient Enrollment for Part A of Phase 2 Study Evaluating THR-149 for Treatment of Diabetic Macular Edema (DME) Oxurion NV
05-Jun-2021 3 Exclusive Speaker Interviews Released ahead of Microbiology West Coast Virtual Conference in 2 weeks SMi Group
04-Jun-2021 Achilles Therapeutics Details Phase I/IIa Clinical Trial Design of CHIRON in Patients with Advanced Non-Small Cell Lung Cancer at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting Achilles Therapeutics
04-Jun-2021 iTeos Therapeutics Announces New Phase 1/2a Data Indicating Antitumor Activity of inupadenant, its Adenosine A2A Receptor Antagonist, at ASCO 2021 iTeos Therapeutics
04-Jun-2021 LINK Medical and Insife partnership combines full CRO services with powerful safety and pharmacovigilance tools LINK Medical
04-Jun-2021 Sleep Apnea Devices Industry – Global Revenue Growth Predictions MarketsandMarkets Research Private Ltd.
04-Jun-2021 Healthcare IT Market - Global Industry is Expecting a Major Makeover in Near Future MarketsandMarkets Research Private Ltd.
04-Jun-2021 API Market – This is How Pandemic Has Affected the Global API Manufacturing MarketsandMarkets Research Private Ltd.
04-Jun-2021 Emerging Trends to Boost Global Revenue for the Medical Equipment Maintenance Market MarketsandMarkets Research Private Ltd.
04-Jun-2021 Novartis continues to push the boundaries of innovation, reimagining medicine, with bold science as it today unveils strong presence at ASCO, including overall survival data in prostate and breast cancer Novartis
04-Jun-2021 Immutep reports positive final data from the INSIGHT-004 phase I study of LAG-3 therapy, Efti, at ASCO 2021 Immutep Limited